Health & Biotech
What’s next for Cardiex as ‘wearables’ trial gets underway
Antisense Therapeutics looks to give boys a lifeline; launches DMD Phase 2 trial
GTG is still pitching its diagnostics even after switching to blockchain
Viagra mouth spray maker Suda says it’s getting a better rise out of the US
No crap: Immuron is one step closer to an anti-gastro pill
MyFiziq is working on a selfie app that predicts if your body fat will make you sick
QBL’s acquisition target caught up in social media allegations
MMJ is now the ASX’s first recreational cannabis dealer after Canadian pact
MGC Pharma now owns one of the most advanced cannabis production facilities in Europe
Medtech guide: these high-tech health stocks have the machines that go ‘ping’
The Hydroponics Company expects to be making cannabis oils by early 2019
ACCC alleges ‘gun-jumping’ by Cryosite in new lawsuit
China-focused infant formula maker a2 Milk is about to post a 68pc revenue lift
Actinogen adds new trial sites to speed up patient recruitment for its clinical trial of novel Alzheimer’s drug
Cellmid just got its anti-ageing, hair loss treatment into two major US stores
Admedus just put a 3D heart valve device into a live sheep for the first time
Regeneus secures valuable US patent as it looks to a licensing deal
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
